Cite
Immune-Mediated Glycocalyx Remodeling in Hospitalized COVID-19 Patients
MLA
Scott L. Hummel, et al. “Immune-Mediated Glycocalyx Remodeling in Hospitalized COVID-19 Patients.” Cardiovascular Drugs and Therapy, vol. 37, Nov. 2021, pp. 307–13. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4c9de24750d57a33e96f465f27c79f08&authtype=sso&custid=ns315887.
APA
Scott L. Hummel, Joanna M. Wells, Sascha N. Goonewardena, Robert S. Rosenson, Olga Grushko, Lauren Herty, & Jacob M. Haus. (2021). Immune-Mediated Glycocalyx Remodeling in Hospitalized COVID-19 Patients. Cardiovascular Drugs and Therapy, 37, 307–313.
Chicago
Scott L. Hummel, Joanna M. Wells, Sascha N. Goonewardena, Robert S. Rosenson, Olga Grushko, Lauren Herty, and Jacob M. Haus. 2021. “Immune-Mediated Glycocalyx Remodeling in Hospitalized COVID-19 Patients.” Cardiovascular Drugs and Therapy 37 (November): 307–13. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4c9de24750d57a33e96f465f27c79f08&authtype=sso&custid=ns315887.